WAAG
NMTC icon

Wealth Alliance Advisory Group’s NeuroOne Medical Technologies NMTC Stock Holding History

Wealth Alliance Advisory Group’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,250
Closed -$30.8K – 197
2023
Q4 		$30.8K Buy
+3,250
New +$23.9K 0.01% 180

Other funds holding NMTC

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Wealth Alliance Advisory Group's NMTC Position: Q1 2024 in Review

Wealth Alliance Advisory Group sold out of NeuroOne Medical Technologies (NMTC) in Q1 2024, closing a stake of 3,250 shares — an estimated $30.8K sold.

Wealth Alliance Advisory Group first reported a position in NMTC in Q4 2023 and held it in 1 quarter. The position peaked at $30.8K in Q4 2023. 18 funds tracked by Wall St. Rank hold NMTC as of Q1 2024.

  • Wealth Alliance Advisory Group reported no remaining NeuroOne Medical Technologies position as of Q1 2024 after selling out during the quarter.
  • Wealth Alliance Advisory Group sold 3,250 NeuroOne Medical Technologies shares in Q1 2024, an estimated $30.8K.
  • Wealth Alliance Advisory Group first reported a position in NeuroOne Medical Technologies in Q4 2023 and held it in 1 quarter.
  • Wealth Alliance Advisory Group's NeuroOne Medical Technologies position peaked at $30.8K in Q4 2023.
  • 18 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q1 2024.

Based on Wealth Alliance Advisory Group's 13F filing for Q1 2024, filed 15 Apr 2024.